MARKET

PTI

PTI

Proteostasis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.960
+0.030
+1.55%
After Hours: 1.990 +0.03 +1.53% 19:27 01/17 EST
OPEN
1.970
PREV CLOSE
1.930
HIGH
2.000
LOW
1.900
VOLUME
1.97M
TURNOVER
--
52 WEEK HIGH
4.720
52 WEEK LOW
0.6100
MARKET CAP
100.21M
P/E (TTM)
-1.5229
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PTI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PTI News

  • Proteostasis Therapeutics Option Alert: Fri $1 Calls Sweep (5) near the Ask: 1600 @ $0.95 vs 2418 OI; Ref=$1.95
  • Benzinga.4d ago
  • DDD, NVTA among premarket gainers
  • Seeking Alpha - Article.5d ago
  • Proteostasis Therapeutics Regulatory Update Following Scientific Advice Meeting with MHRA
  • PR Newswire.5d ago
  • The Proteostasis Therapeutics (NASDAQ:PTI) Share Price Is Down 84% So Some Shareholders Are Rather Upset
  • Simply Wall St..01/09 17:16

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About PTI

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. The Company focuses on identifying therapies that restore protein function. The Company’s CF focused pipeline consists of novel CFTR modulators including correctors, potentiators and amplifiers. The Company’s clinical developments include PTI-801, a third generation CFTR corrector, PTI-808, a CFTR potentiator, and PTI-428, a CFTR amplifier.
More

Webull offers Proteostasis Therapeutics Inc (PTI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.